Intracoronary Administration of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells Improves Myocardial Perfusion But Not Left Ventricle Function, in a Translational Model of Acute Myocardial Infarction

Autologous adipose tissue-derived mesenchymal stem cells (s) therapy is a promising strategy to improve post-myocardial infarction outcomes. In a porcine model of acute myocardial infarction, we studied the long-term effects and the mechanisms involved in allogeneic s administration on myocardial pe...

Descripción completa

Detalles Bibliográficos
Autores: Bobi, Joaquim|||0000-0002-9026-5226, Solanes, Núria, Fernández-Jiménez, Rodrigo, Galán-Arriola, Carlos, Dantas, A. P.|||0000-0001-8514-4094, Fernández-Friera, Leticia, Gálvez-Montón, Carolina|||0000-0003-2254-9371, Rigol-Monzó, Elisabet, Agüero, Jaume|||0000-0001-7416-871X, Ramírez, José, Roqué, Mercè, Bayés-Genís, Antoni|||0000-0002-3044-197X, Sánchez González, Javier|||0000-0003-1427-3870, García-Álvarez, Ana|||0000-0002-1718-2424, Sabaté, Manel, Rudilla, F.., Ibañez, Borja|||0000-0002-5036-254X, Rigol, Montserrat
Tipo de recurso: artículo
Fecha de publicación:2017
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:186231
Acceso en línea:https://ddd.uab.cat/record/186231
https://dx.doi.org/urn:doi:10.1161/JAHA.117.005771
Access Level:acceso abierto
Palabra clave:Adipose tissue-derived mesenchymal stem cells
Allogeneic origin
Myocardial infarction
Myocardial perfusion
Vascular density
Cell Therapy
Stem Cells
Myocardial Infarction
Translational Studies
Descripción
Sumario:Autologous adipose tissue-derived mesenchymal stem cells (s) therapy is a promising strategy to improve post-myocardial infarction outcomes. In a porcine model of acute myocardial infarction, we studied the long-term effects and the mechanisms involved in allogeneic s administration on myocardial performance. Thirty-eight pigs underwent 50 minutes of coronary occlusion; the study was completed in 33 pigs. After reperfusion, allogeneic s or culture medium (vehicle) were intracoronarily administered. Follow-ups were performed at short (2 days after acute myocardial infarction vehicle-treated, n=10; s-treated, n=9) or long term (60 days after acute myocardial infarction vehicle-treated, n=7; s-treated, n=7). At short term, infarcted myocardium analysis showed reduced apoptosis in the s-treated animals (48.6±6% versus 55.9±5.7% in vehicle; P =0.017); enhancement of the reparative process with up-regulated vascular endothelial growth factor, granulocyte macrophage colony-stimulating factor, and stromal-derived factor-1α gene expression; and increased M2 macrophages (67.2±10% versus 54.7±10.2% in vehicle; P =0.016). In long-term groups, increase in myocardial perfusion at the anterior infarct border was observed both on day-7 and day-60 cardiac magnetic resonance studies in s-treated animals, compared to vehicle (87.9±28.7 versus 57.4±17.7 mL/min per gram at 7 days; P =0.034 and 99±22.6 versus 43.3±14.7 22.6 mL/min per gram at 60 days; P =0.0001, respectively). At day 60, higher vascular density was detected at the border zone in the s-treated animals (118±18 versus 92.4±24.3 vessels/mm 2 in vehicle; P =0.045). Cardiac magnetic resonance-measured left ventricular ejection fraction of left ventricular volumes was not different between groups at any time point. In this porcine acute myocardial infarction model, allogeneic s-based therapy was associated with increased cardioprotective and reparative mechanisms and with better cardiac magnetic resonance-measured perfusion. No effect on left ventricular volumes or ejection fraction was observed.